leading pharmaceutical glp-1 treatments 2025’s Breakthrough Obesity Treatments: Top Companies & Innovations What is the pipeline for
Description
It involves more than just diet and exercise
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for diabetes and obesity, exhibit pleiotropic effectsincluding anti-inflammatory, ...
A large, retrospective study conducted by scientists at The University of Texas at San Antonio suggests that people taking glucagon-like peptide-1 (GLP-1) receptor agonists medications that are widely prescribed for metabolic disease have a significantly lower risk of developing colorectal cancer compared with those taking aspirin.
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
Mini versions of aesthetic treatments are getting outsize attention.
